Close
Nordic 9Nordic 9

Consolidated Holdings A/S (investor - Others)

Denmark
See something wrong or missing? Let us know
Offices:Copenhagen
Registration number:35422013

Consolidated Holdings A/S is a company owned by Ib Kunøe

Average round investment:7.28M USD
Average number per year:1.0
Distribution: 2022 (1)2019 (1)
Portfolio companies: Denmark MonTa Biosciences
Mostly invests in: Denmark Denmark (2) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Consolidated Holdings A/S

Name Criteria
United States Broadview Ventures
63%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
China Zhejiang NHU
63%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Denmark Selfinvest
63%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Italy Giampaolo Cagnin
63%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Japan Yokogawa Electric Corporation
63%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Norway Viking Venture
62%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
France Advent France Biotechnology
60%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain CG Health Ventures
60%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain Ekarpen
60%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Hillclimber
60%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top